School Of Medicine Basic Sciences

Phase I clinical trial of a drug was successfully completed at the Warren Center for Neuroscience Drug Discovery, with promise to treat Alzheimer’s and other neurodegenerative diseases. The compound, named VU319, is the first Vanderbilt end-to-end drug discovery effort related to memory loss, starting from the earliest basic science research through human clinical trials. Read More

The School of Medicine Basic Sciences and the Office of the Vice Provost for Research and Innovation launch the Innovation Ignition Fund. This pilot program offers up to $500,000 in funding and drug development mentorship from Vanderbilt scientists with expertise in translational research. Read More

An international collaboration led by Vanderbilt researchers has identified a key component in lesions associated with age-related macular degeneration (AMD), a leading cause of blindness in older adults. Read More

A potential schizophrenia treatment discovered through the Warren Center for Neuroscience Drug Discovery has been cleared by the U.S. Food and Drug Administration for use in phase 1 clinical trials—the third WCNDD therapeutic to reach that benchmark.  “Vanderbilt is proud that a discovery by our researchers at the Warren Center… Read More

“Looking back, the trip did exactly what I hoped it would: It exposed me to the vast array of career paths available to graduate students like me, from R&D and business management to investing and consulting. The connections I made with my peers, various speakers, and Vanderbilt alums are invaluable as I think about  what’s my next step,” said Amy Tran. Read More

By Kate Carter To highlight major inflection points in research, the Vanderbilt School of Medicine Basic Sciences launched the Apex Lecture Series in 2023, which allows the Basic Sciences community to engage with researchers from around the world who are influencing the trajectory of their fields. Read More

Nancy Carrasco, MD Please join us in congratulating Nancy Carrasco, Joe C. Davis Chair in Biomedical Science and chair of the Department of Molecular Physiology and Biophysics, for receiving the 2024 Award for the Biophysics of Health and Disease from the Biophysical Society. Carrasco’s lab focuses on understanding… Read More

Md. Jashim Uddin Md. Jashim Uddin, research associate professor of biochemistry, has received the Phi Beta Psi national research award for the second year in a row. The award will fund an ongoing project in which Uddin and colleagues are working to develop an improved cancer imaging platform… Read More

A long-acting antibody combination discovered at Vanderbilt University Medical Center that protects against COVID-19 in high-risk individuals, and which was optimized and developed by the global pharmaceutical company AstraZeneca, has received a gold medal in the 2022 R&D 100 awards program announced Aug. 22 by R&D World Magazine. Now… Read More

Linh Trinh, a cell and developmental biology Ph.D. student, won the inaugural Brighter Ventures Student Award for her research on the Sox17 gene and its surrounding regulatory network shape cell fate during organ development. The award was established by pharmacology alum Laurent Audoly, PhD’97, and his wife Olga Granaturova. Read More